Neuland Laboratories Limited has responded to a query from BSE Limited regarding a significant increase in the volume of its security across exchanges. The company stated that it has been and will continue to disclose all necessary information in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and has not withheld any material information that would affect the volume behavior of its stock.
Neuland Laboratories clarified that its equity shares are freely traded on the stock exchanges, and the company cannot comment on the reasons for the increase in trading volume. The company reiterated its commitment to compliance with SEBI Listing Regulations and assured that any information likely to affect share volume would be disclosed to the stock exchanges in a timely manner.
The company's response was addressed to both BSE Limited and the National Stock Exchange of India, emphasizing its commitment to transparency and regulatory compliance.
Sarada Bhamidipati, the Company Secretary of Neuland Laboratories Limited, digitally signed the clarification, underscoring the company's adherence to corporate governance standards.
